UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:RET-FGFR3 |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: RET-FGFR3 | FusionPDB ID: 73557 | FusionGDB2.0 ID: 73557 | Hgene | Tgene | Gene symbol | RET | FGFR3 | Gene ID | 5979 | 2261 |
Gene name | ret proto-oncogene | fibroblast growth factor receptor 3 | |
Synonyms | CDHF12|CDHR16|HSCR1|MEN2A|MEN2B|MTC1|PTC|RET-ELE1 | ACH|CD333|CEK2|HSFGFR3EX|JTK4 | |
Cytomap | 10q11.21 | 4p16.3 | |
Type of gene | protein-coding | protein-coding | |
Description | proto-oncogene tyrosine-protein kinase receptor RetRET receptor tyrosine kinasecadherin family member 12cadherin-related family member 16proto-oncogene c-Retrearranged during transfectionret proto-oncogene (multiple endocrine neoplasia and medullary | fibroblast growth factor receptor 3FGFR-3fibroblast growth factor receptor 3 variant 4fibroblast growth factor receptor 3-Shydroxyaryl-protein kinasetyrosine kinase JTK4 | |
Modification date | 20200322 | 20200313 | |
UniProtAcc | RTL1 | P22607 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000340058, ENST00000355710, | ENST00000474521, ENST00000260795, ENST00000340107, ENST00000352904, ENST00000412135, ENST00000440486, ENST00000481110, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 9 X 6 X 4=216 | 6 X 11 X 9=594 |
# samples | 9 | 9 | |
** MAII score | log2(9/216*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(9/594*10)=-2.72246602447109 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: RET [Title/Abstract] AND FGFR3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | RET(43612179)-FGFR3(1807285), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | RET-FGFR3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. RET-FGFR3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. RET-FGFR3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. RET-FGFR3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | RET | GO:0030155 | regulation of cell adhesion | 21357690 |
Hgene | RET | GO:0030335 | positive regulation of cell migration | 20702524 |
Hgene | RET | GO:0033619 | membrane protein proteolysis | 21357690 |
Hgene | RET | GO:0033630 | positive regulation of cell adhesion mediated by integrin | 20702524 |
Hgene | RET | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway | 28953886 |
Hgene | RET | GO:0043410 | positive regulation of MAPK cascade | 28846099 |
Tgene | FGFR3 | GO:0008543 | fibroblast growth factor receptor signaling pathway | 8663044 |
Tgene | FGFR3 | GO:0018108 | peptidyl-tyrosine phosphorylation | 11294897 |
Tgene | FGFR3 | GO:0046777 | protein autophosphorylation | 11294897 |
Fusion gene breakpoints across RET (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across FGFR3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-FP-7916 | RET | chr10 | 43612179 | + | FGFR3 | chr4 | 1807285 | + |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000355710 | RET | chr10 | 43612179 | + | ENST00000481110 | FGFR3 | chr4 | 1807285 | + | 4935 | 2516 | 232 | 3357 | 1041 |
ENST00000355710 | RET | chr10 | 43612179 | + | ENST00000440486 | FGFR3 | chr4 | 1807285 | + | 5013 | 2516 | 232 | 3402 | 1056 |
ENST00000355710 | RET | chr10 | 43612179 | + | ENST00000412135 | FGFR3 | chr4 | 1807285 | + | 5013 | 2516 | 232 | 3402 | 1056 |
ENST00000355710 | RET | chr10 | 43612179 | + | ENST00000340107 | FGFR3 | chr4 | 1807285 | + | 5013 | 2516 | 232 | 3402 | 1056 |
ENST00000355710 | RET | chr10 | 43612179 | + | ENST00000260795 | FGFR3 | chr4 | 1807285 | + | 5012 | 2516 | 232 | 3402 | 1056 |
ENST00000355710 | RET | chr10 | 43612179 | + | ENST00000352904 | FGFR3 | chr4 | 1807285 | + | 5012 | 2516 | 232 | 3402 | 1056 |
ENST00000340058 | RET | chr10 | 43612179 | + | ENST00000481110 | FGFR3 | chr4 | 1807285 | + | 4883 | 2464 | 180 | 3305 | 1041 |
ENST00000340058 | RET | chr10 | 43612179 | + | ENST00000440486 | FGFR3 | chr4 | 1807285 | + | 4961 | 2464 | 180 | 3350 | 1056 |
ENST00000340058 | RET | chr10 | 43612179 | + | ENST00000412135 | FGFR3 | chr4 | 1807285 | + | 4961 | 2464 | 180 | 3350 | 1056 |
ENST00000340058 | RET | chr10 | 43612179 | + | ENST00000340107 | FGFR3 | chr4 | 1807285 | + | 4961 | 2464 | 180 | 3350 | 1056 |
ENST00000340058 | RET | chr10 | 43612179 | + | ENST00000260795 | FGFR3 | chr4 | 1807285 | + | 4960 | 2464 | 180 | 3350 | 1056 |
ENST00000340058 | RET | chr10 | 43612179 | + | ENST00000352904 | FGFR3 | chr4 | 1807285 | + | 4960 | 2464 | 180 | 3350 | 1056 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000355710 | ENST00000481110 | RET | chr10 | 43612179 | + | FGFR3 | chr4 | 1807285 | + | 0.001215983 | 0.998784 |
ENST00000355710 | ENST00000440486 | RET | chr10 | 43612179 | + | FGFR3 | chr4 | 1807285 | + | 0.000537798 | 0.9994622 |
ENST00000355710 | ENST00000412135 | RET | chr10 | 43612179 | + | FGFR3 | chr4 | 1807285 | + | 0.000537798 | 0.9994622 |
ENST00000355710 | ENST00000340107 | RET | chr10 | 43612179 | + | FGFR3 | chr4 | 1807285 | + | 0.000537798 | 0.9994622 |
ENST00000355710 | ENST00000260795 | RET | chr10 | 43612179 | + | FGFR3 | chr4 | 1807285 | + | 0.00053857 | 0.9994615 |
ENST00000355710 | ENST00000352904 | RET | chr10 | 43612179 | + | FGFR3 | chr4 | 1807285 | + | 0.00053857 | 0.9994615 |
ENST00000340058 | ENST00000481110 | RET | chr10 | 43612179 | + | FGFR3 | chr4 | 1807285 | + | 0.001168573 | 0.99883145 |
ENST00000340058 | ENST00000440486 | RET | chr10 | 43612179 | + | FGFR3 | chr4 | 1807285 | + | 0.000521809 | 0.99947816 |
ENST00000340058 | ENST00000412135 | RET | chr10 | 43612179 | + | FGFR3 | chr4 | 1807285 | + | 0.000521809 | 0.99947816 |
ENST00000340058 | ENST00000340107 | RET | chr10 | 43612179 | + | FGFR3 | chr4 | 1807285 | + | 0.000521809 | 0.99947816 |
ENST00000340058 | ENST00000260795 | RET | chr10 | 43612179 | + | FGFR3 | chr4 | 1807285 | + | 0.000522567 | 0.99947745 |
ENST00000340058 | ENST00000352904 | RET | chr10 | 43612179 | + | FGFR3 | chr4 | 1807285 | + | 0.000522567 | 0.99947745 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >73557_73557_1_RET-FGFR3_RET_chr10_43612179_ENST00000340058_FGFR3_chr4_1807285_ENST00000260795_length(amino acids)=1056AA_BP=6 MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQE DTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENR PPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAP TFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNR NLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCS TLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGR CEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLC DELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFP RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAK GNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKK TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPT -------------------------------------------------------------- >73557_73557_2_RET-FGFR3_RET_chr10_43612179_ENST00000340058_FGFR3_chr4_1807285_ENST00000340107_length(amino acids)=1056AA_BP=6 MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQE DTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENR PPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAP TFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNR NLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCS TLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGR CEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLC DELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFP RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAK GNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKK TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPT -------------------------------------------------------------- >73557_73557_3_RET-FGFR3_RET_chr10_43612179_ENST00000340058_FGFR3_chr4_1807285_ENST00000352904_length(amino acids)=1056AA_BP=6 MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQE DTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENR PPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAP TFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNR NLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCS TLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGR CEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLC DELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFP RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAK GNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKK TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPT -------------------------------------------------------------- >73557_73557_4_RET-FGFR3_RET_chr10_43612179_ENST00000340058_FGFR3_chr4_1807285_ENST00000412135_length(amino acids)=1056AA_BP=6 MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQE DTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENR PPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAP TFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNR NLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCS TLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGR CEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLC DELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFP RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAK GNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKK TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPT -------------------------------------------------------------- >73557_73557_5_RET-FGFR3_RET_chr10_43612179_ENST00000340058_FGFR3_chr4_1807285_ENST00000440486_length(amino acids)=1056AA_BP=6 MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQE DTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENR PPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAP TFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNR NLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCS TLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGR CEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLC DELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFP RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAK GNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKK TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPT -------------------------------------------------------------- >73557_73557_6_RET-FGFR3_RET_chr10_43612179_ENST00000340058_FGFR3_chr4_1807285_ENST00000481110_length(amino acids)=1041AA_BP=6 MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQE DTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENR PPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAP TFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNR NLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCS TLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGR CEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLC DELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFP RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAK GNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKK TTNLVLWGPALGDLHAGGLPVPRHPCGGALQAAEGGPPHGQARQLHTRPVHDHAGVLACRALPEAHLQAAGGGPGPCPYRDVHRRVPGPV -------------------------------------------------------------- >73557_73557_7_RET-FGFR3_RET_chr10_43612179_ENST00000355710_FGFR3_chr4_1807285_ENST00000260795_length(amino acids)=1056AA_BP=6 MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQE DTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENR PPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAP TFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNR NLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCS TLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGR CEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLC DELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFP RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAK GNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKK TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPT -------------------------------------------------------------- >73557_73557_8_RET-FGFR3_RET_chr10_43612179_ENST00000355710_FGFR3_chr4_1807285_ENST00000340107_length(amino acids)=1056AA_BP=6 MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQE DTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENR PPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAP TFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNR NLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCS TLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGR CEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLC DELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFP RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAK GNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKK TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPT -------------------------------------------------------------- >73557_73557_9_RET-FGFR3_RET_chr10_43612179_ENST00000355710_FGFR3_chr4_1807285_ENST00000352904_length(amino acids)=1056AA_BP=6 MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQE DTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENR PPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAP TFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNR NLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCS TLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGR CEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLC DELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFP RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAK GNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKK TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPT -------------------------------------------------------------- >73557_73557_10_RET-FGFR3_RET_chr10_43612179_ENST00000355710_FGFR3_chr4_1807285_ENST00000412135_length(amino acids)=1056AA_BP=6 MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQE DTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENR PPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAP TFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNR NLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCS TLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGR CEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLC DELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFP RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAK GNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKK TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPT -------------------------------------------------------------- >73557_73557_11_RET-FGFR3_RET_chr10_43612179_ENST00000355710_FGFR3_chr4_1807285_ENST00000440486_length(amino acids)=1056AA_BP=6 MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQE DTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENR PPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAP TFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNR NLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCS TLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGR CEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLC DELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFP RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAK GNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKK TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHDLYMIMRECWHAAPSQRPT -------------------------------------------------------------- >73557_73557_12_RET-FGFR3_RET_chr10_43612179_ENST00000355710_FGFR3_chr4_1807285_ENST00000481110_length(amino acids)=1041AA_BP=6 MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQE DTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENR PPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAP TFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNR NLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCS TLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGR CEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLC DELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFP RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQGGPLYVLVEYAAK GNLREFLRARRPPGLDYSFDTCKPPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNLDYYKK TTNLVLWGPALGDLHAGGLPVPRHPCGGALQAAEGGPPHGQARQLHTRPVHDHAGVLACRALPEAHLQAAGGGPGPCPYRDVHRRVPGPV -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr10:43612179/chr4:1807285) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
RET | FGFR3 |
1358 | FUNCTION: Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation and apoptosis. Plays an essential role in the regulation of chondrocyte differentiation, proliferation and apoptosis, and is required for normal skeleton development. Regulates both osteogenesis and postnatal bone mineralization by osteoblasts. Promotes apoptosis in chondrocytes, but can also promote cancer cell proliferation. Required for normal development of the inner ear. Phosphorylates PLCG1, CBL and FRS2. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Plays a role in the regulation of vitamin D metabolism. Mutations that lead to constitutive kinase activation or impair normal FGFR3 maturation, internalization and degradation lead to aberrant signaling. Over-expressed or constitutively activated FGFR3 promotes activation of PTPN11/SHP2, STAT1, STAT5A and STAT5B. Secreted isoform 3 retains its capacity to bind FGF1 and FGF2 and hence may interfere with FGF signaling. {ECO:0000269|PubMed:10611230, ECO:0000269|PubMed:11294897, ECO:0000269|PubMed:11703096, ECO:0000269|PubMed:14534538, ECO:0000269|PubMed:16410555, ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:17145761, ECO:0000269|PubMed:17311277, ECO:0000269|PubMed:17509076, ECO:0000269|PubMed:17561467, ECO:0000269|PubMed:19088846, ECO:0000269|PubMed:19286672, ECO:0000269|PubMed:8663044}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | RET | chr10:43612179 | chr4:1807285 | ENST00000340058 | + | 12 | 19 | 168_272 | 761.3333333333334 | 1073.0 | Domain | Cadherin |
Hgene | RET | chr10:43612179 | chr4:1807285 | ENST00000355710 | + | 12 | 20 | 168_272 | 761.3333333333334 | 1115.0 | Domain | Cadherin |
Hgene | RET | chr10:43612179 | chr4:1807285 | ENST00000340058 | + | 12 | 19 | 730_738 | 761.3333333333334 | 1073.0 | Nucleotide binding | ATP |
Hgene | RET | chr10:43612179 | chr4:1807285 | ENST00000355710 | + | 12 | 20 | 730_738 | 761.3333333333334 | 1115.0 | Nucleotide binding | ATP |
Hgene | RET | chr10:43612179 | chr4:1807285 | ENST00000340058 | + | 12 | 19 | 29_635 | 761.3333333333334 | 1073.0 | Topological domain | Extracellular |
Hgene | RET | chr10:43612179 | chr4:1807285 | ENST00000355710 | + | 12 | 20 | 29_635 | 761.3333333333334 | 1115.0 | Topological domain | Extracellular |
Hgene | RET | chr10:43612179 | chr4:1807285 | ENST00000340058 | + | 12 | 19 | 636_657 | 761.3333333333334 | 1073.0 | Transmembrane | Helical |
Hgene | RET | chr10:43612179 | chr4:1807285 | ENST00000355710 | + | 12 | 20 | 636_657 | 761.3333333333334 | 1115.0 | Transmembrane | Helical |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000352904 | 7 | 15 | 472_761 | 399.3333333333333 | 695.0 | Domain | Protein kinase | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000412135 | 8 | 16 | 472_761 | 399.3333333333333 | 695.0 | Domain | Protein kinase | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000352904 | 7 | 15 | 478_486 | 399.3333333333333 | 695.0 | Nucleotide binding | ATP | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000412135 | 8 | 16 | 478_486 | 399.3333333333333 | 695.0 | Nucleotide binding | ATP | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000352904 | 7 | 15 | 397_806 | 399.3333333333333 | 695.0 | Topological domain | Cytoplasmic | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000412135 | 8 | 16 | 397_806 | 399.3333333333333 | 695.0 | Topological domain | Cytoplasmic |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | RET | chr10:43612179 | chr4:1807285 | ENST00000340058 | + | 12 | 19 | 724_1016 | 761.3333333333334 | 1073.0 | Domain | Protein kinase |
Hgene | RET | chr10:43612179 | chr4:1807285 | ENST00000355710 | + | 12 | 20 | 724_1016 | 761.3333333333334 | 1115.0 | Domain | Protein kinase |
Hgene | RET | chr10:43612179 | chr4:1807285 | ENST00000340058 | + | 12 | 19 | 805_807 | 761.3333333333334 | 1073.0 | Region | Note=Inhibitors binding |
Hgene | RET | chr10:43612179 | chr4:1807285 | ENST00000355710 | + | 12 | 20 | 805_807 | 761.3333333333334 | 1115.0 | Region | Note=Inhibitors binding |
Hgene | RET | chr10:43612179 | chr4:1807285 | ENST00000340058 | + | 12 | 19 | 658_1114 | 761.3333333333334 | 1073.0 | Topological domain | Cytoplasmic |
Hgene | RET | chr10:43612179 | chr4:1807285 | ENST00000355710 | + | 12 | 20 | 658_1114 | 761.3333333333334 | 1115.0 | Topological domain | Cytoplasmic |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000260795 | 9 | 17 | 151_244 | 511.3333333333333 | 807.0 | Domain | Note=Ig-like C2-type 2 | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000260795 | 9 | 17 | 24_126 | 511.3333333333333 | 807.0 | Domain | Note=Ig-like C2-type 1 | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000260795 | 9 | 17 | 253_355 | 511.3333333333333 | 807.0 | Domain | Note=Ig-like C2-type 3 | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000260795 | 9 | 17 | 472_761 | 511.3333333333333 | 807.0 | Domain | Protein kinase | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000340107 | 10 | 18 | 151_244 | 513.3333333333334 | 809.0 | Domain | Note=Ig-like C2-type 2 | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000340107 | 10 | 18 | 24_126 | 513.3333333333334 | 809.0 | Domain | Note=Ig-like C2-type 1 | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000340107 | 10 | 18 | 253_355 | 513.3333333333334 | 809.0 | Domain | Note=Ig-like C2-type 3 | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000340107 | 10 | 18 | 472_761 | 513.3333333333334 | 809.0 | Domain | Protein kinase | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000352904 | 7 | 15 | 151_244 | 399.3333333333333 | 695.0 | Domain | Note=Ig-like C2-type 2 | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000352904 | 7 | 15 | 24_126 | 399.3333333333333 | 695.0 | Domain | Note=Ig-like C2-type 1 | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000352904 | 7 | 15 | 253_355 | 399.3333333333333 | 695.0 | Domain | Note=Ig-like C2-type 3 | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000412135 | 8 | 16 | 151_244 | 399.3333333333333 | 695.0 | Domain | Note=Ig-like C2-type 2 | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000412135 | 8 | 16 | 24_126 | 399.3333333333333 | 695.0 | Domain | Note=Ig-like C2-type 1 | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000412135 | 8 | 16 | 253_355 | 399.3333333333333 | 695.0 | Domain | Note=Ig-like C2-type 3 | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000440486 | 10 | 18 | 151_244 | 511.3333333333333 | 807.0 | Domain | Note=Ig-like C2-type 2 | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000440486 | 10 | 18 | 24_126 | 511.3333333333333 | 807.0 | Domain | Note=Ig-like C2-type 1 | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000440486 | 10 | 18 | 253_355 | 511.3333333333333 | 807.0 | Domain | Note=Ig-like C2-type 3 | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000440486 | 10 | 18 | 472_761 | 511.3333333333333 | 807.0 | Domain | Protein kinase | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000260795 | 9 | 17 | 478_486 | 511.3333333333333 | 807.0 | Nucleotide binding | ATP | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000340107 | 10 | 18 | 478_486 | 513.3333333333334 | 809.0 | Nucleotide binding | ATP | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000440486 | 10 | 18 | 478_486 | 511.3333333333333 | 807.0 | Nucleotide binding | ATP | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000260795 | 9 | 17 | 23_375 | 511.3333333333333 | 807.0 | Topological domain | Extracellular | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000260795 | 9 | 17 | 397_806 | 511.3333333333333 | 807.0 | Topological domain | Cytoplasmic | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000340107 | 10 | 18 | 23_375 | 513.3333333333334 | 809.0 | Topological domain | Extracellular | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000340107 | 10 | 18 | 397_806 | 513.3333333333334 | 809.0 | Topological domain | Cytoplasmic | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000352904 | 7 | 15 | 23_375 | 399.3333333333333 | 695.0 | Topological domain | Extracellular | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000412135 | 8 | 16 | 23_375 | 399.3333333333333 | 695.0 | Topological domain | Extracellular | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000440486 | 10 | 18 | 23_375 | 511.3333333333333 | 807.0 | Topological domain | Extracellular | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000440486 | 10 | 18 | 397_806 | 511.3333333333333 | 807.0 | Topological domain | Cytoplasmic | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000260795 | 9 | 17 | 376_396 | 511.3333333333333 | 807.0 | Transmembrane | Helical | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000340107 | 10 | 18 | 376_396 | 513.3333333333334 | 809.0 | Transmembrane | Helical | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000352904 | 7 | 15 | 376_396 | 399.3333333333333 | 695.0 | Transmembrane | Helical | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000412135 | 8 | 16 | 376_396 | 399.3333333333333 | 695.0 | Transmembrane | Helical | |
Tgene | FGFR3 | chr10:43612179 | chr4:1807285 | ENST00000440486 | 10 | 18 | 376_396 | 511.3333333333333 | 807.0 | Transmembrane | Helical |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
FGFR3 | C6orf47, SMG7, BORA, CCDC17, HBZ, HNRNPL, NDUFS6, RNF130, ATF3, ARAP1, CHGB, CTSK, RADIL, GTF3C1, KRT8, POLA2, KIAA1377, RPL8, SLC25A6, Sh2b1, SH2B1, FGF9, FGF1, GRB2, FGF8, HSP90AA1, HSP90AB1, HSPA1B, HSPA8, CDC37, HSPA4, SOCS1, SOCS3, FGFR3, SNX11, TMEM231, ILKAP, SRPK2, PVRL1, BRD4, VHL, FNTA, CDK6, FGFR2, TMEM30B, ARRDC3, SDC2, EPHA4, KAL1, RPS6KA3, fgf3, KLB, CSPG4, HEXIM1, LARP7, MAP3K4, CDC25A, DCXR, ERBB2, BRD2, OXT, PRKAR1A, POMC, CUL4B, ATG5, MKRN2, ABCA2, CTLA4, POTEI, TNFRSF10A, MPDZ, SDC4, CLEC4A, CRLF2, FBXO2, ALG6, TM2D3, KLK1, PI15, FSTL4, PRG2, TMEM87A, PDGFRA, LY86, MFAP4, FHL3, DNASE1L1, CELA2B, FBXO6, SIRPD, CBLN4, KLK3, EDN3, PRTN3, ELSPBP1, LYPD4, GGH, GPIHBP1, IL5RA, DNAJB9, TCTN1, UQCC1, LIPG, FCGR3B, SDF2L1, EPDR1, ADAMTS12, IGLL5, CFC1, C1QB, |
RET | STAT3, DOK6, DOK5, SRC, SHC1, PTPRF, DOK2, DOK4, DOK1, GRB2, CRK, PLCG1, PDLIM7, GRB7, FRS2, NRTN, GFRA1, GRB10, IKBKG, MCRS1, CBL, CBLC, RET, HSP90AA1, NOTCH2NL, NOTCH3, AIP, EGFR, NTRK1, ZBTB48, HNRNPD, SORT1, SYNCRIP, SGTB, BAG6, HIST1H3A, KYNU, TXNL4A, ZCCHC8, ICE2, MAPK3, PTK2, MAPK1, PTPRR, DUSP26, Shc1, PIK3R1, FBXO7, NEDD4, SHANK2, LRRK1, PTK6, CTNNB1, SHC4, ERBB2, ADAM10, SPINT2, PCDH7, LRIG2, APP, GDNF, IGF1R, CLU, EPCAM, CDH2, TGFBR1, PTK7, FAT1, DHCR24, SMN1, PCDH19, NCSTN, CERS2, CHP1, FANCD2, ITM2C, SEL1L, PCDHGB5, CKB, NRP1, PLXNB2, NCK2, CTNND1, TULP3, PTPN1, NF2, CRKL, CAMLG, NUMB, BASP1, ROR2, NOTCH2, PTPN13, ANK3, RAB3GAP1, PEA15, LLGL1, GPRIN3, RAPH1, MARK2, CYFIP1, ARC, GPRIN1, ANKLE2, VRK2, MIB1, PHACTR4, UNC5B, TMEM57, SYAP1, FAF2, ERBB2IP, FAM129B, KIAA1715, PEAK1, VANGL2, BAIAP2, EPN1, NUMBL, PRKAR2A, GAB1, PTPRA, DDX39A, TIMP1, EPHB4, MANEA, SRY, RABAC1, LEMD3, TMEM214, PDZD8, GPR50, SMIM5, RNF149, SDF2L1, BMPR1A, PLEKHH3, ACVR2A, |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
RET | |
FGFR3 |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to RET-FGFR3 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to RET-FGFR3 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | RET | C1833921 | Familial medullary thyroid carcinoma | 23 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | RET | C3888239 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | 16 | GENOMICS_ENGLAND;UNIPROT |
Hgene | RET | C0025268 | Multiple Endocrine Neoplasia Type 2a | 15 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | RET | C1708353 | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 12 | CLINGEN |
Hgene | RET | C0025269 | Multiple Endocrine Neoplasia Type 2b | 10 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | RET | C0238463 | Papillary thyroid carcinoma | 3 | CTD_human;ORPHANET |
Hgene | RET | C1275808 | Congenital central hypoventilation | 3 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | RET | C1859049 | CCHS WITH HIRSCHSPRUNG DISEASE | 3 | CTD_human;ORPHANET |
Hgene | RET | C0009402 | Colorectal Carcinoma | 2 | CTD_human;UNIPROT |
Hgene | RET | C0009404 | Colorectal Neoplasms | 2 | CTD_human |
Hgene | RET | C0019569 | Hirschsprung Disease | 2 | CTD_human |
Hgene | RET | C0027662 | Multiple Endocrine Neoplasia | 2 | CTD_human;GENOMICS_ENGLAND |
Hgene | RET | C0085758 | Aganglionosis, Colonic | 2 | CTD_human |
Hgene | RET | C0266294 | Unilateral agenesis of kidney | 2 | ORPHANET |
Hgene | RET | C1257840 | Aganglionosis, Rectosigmoid Colon | 2 | CTD_human |
Hgene | RET | C3661523 | Congenital Intestinal Aganglionosis | 2 | CTD_human |
Hgene | RET | C0006413 | Burkitt Lymphoma | 1 | CTD_human |
Hgene | RET | C0031511 | Pheochromocytoma | 1 | CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | RET | C0038220 | Status Epilepticus | 1 | CTD_human |
Hgene | RET | C0040136 | Thyroid Neoplasm | 1 | CGI;CTD_human |
Hgene | RET | C0151468 | Thyroid Gland Follicular Adenoma | 1 | CTD_human |
Hgene | RET | C0206693 | Medullary carcinoma | 1 | CTD_human |
Hgene | RET | C0238462 | Medullary carcinoma of thyroid | 1 | CGI;CTD_human |
Hgene | RET | C0270823 | Petit mal status | 1 | CTD_human |
Hgene | RET | C0311335 | Grand Mal Status Epilepticus | 1 | CTD_human |
Hgene | RET | C0343640 | African Burkitt's lymphoma | 1 | CTD_human |
Hgene | RET | C0393734 | Complex Partial Status Epilepticus | 1 | CTD_human |
Hgene | RET | C0549473 | Thyroid carcinoma | 1 | CGI;CTD_human;UNIPROT |
Hgene | RET | C0740340 | Amyloidosis, Familial | 1 | CTD_human |
Hgene | RET | C0751522 | Status Epilepticus, Subclinical | 1 | CTD_human |
Hgene | RET | C0751523 | Non-Convulsive Status Epilepticus | 1 | CTD_human |
Hgene | RET | C0751524 | Simple Partial Status Epilepticus | 1 | CTD_human |
Hgene | RET | C1257877 | Pheochromocytoma, Extra-Adrenal | 1 | CTD_human |
Hgene | RET | C1609433 | Congenital absence of kidneys syndrome | 1 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Hgene | RET | C3501843 | Nonmedullary Thyroid Carcinoma | 1 | CTD_human |
Hgene | RET | C3501844 | Familial Nonmedullary Thyroid Cancer | 1 | CTD_human |
Hgene | RET | C4721444 | Burkitt Leukemia | 1 | CTD_human |
Tgene | FGFR3 | C0001080 | Achondroplasia | 13 | CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | FGFR3 | C0410529 | Hypochondroplasia (disorder) | 10 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | FGFR3 | C1864436 | Muenke Syndrome | 9 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | FGFR3 | C1868678 | THANATOPHORIC DYSPLASIA, TYPE I (disorder) | 9 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | FGFR3 | C2677099 | CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS (disorder) | 7 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | FGFR3 | C0005684 | Malignant neoplasm of urinary bladder | 6 | CGI;CTD_human;UNIPROT |
Tgene | FGFR3 | C0005695 | Bladder Neoplasm | 4 | CGI;CTD_human |
Tgene | FGFR3 | C1300257 | Thanatophoric dysplasia, type 2 | 4 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | FGFR3 | C1864852 | CATSHL syndrome | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | FGFR3 | C2674173 | Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | FGFR3 | C0265269 | Lacrimoauriculodentodigital syndrome | 2 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | FGFR3 | C0007138 | Carcinoma, Transitional Cell | 1 | CTD_human |
Tgene | FGFR3 | C0008924 | Cleft upper lip | 1 | CTD_human |
Tgene | FGFR3 | C0008925 | Cleft Palate | 1 | CTD_human |
Tgene | FGFR3 | C0014544 | Epilepsy | 1 | GENOMICS_ENGLAND |
Tgene | FGFR3 | C0014547 | Epilepsies, Partial | 1 | GENOMICS_ENGLAND |
Tgene | FGFR3 | C0022603 | Seborrheic keratosis | 1 | UNIPROT |
Tgene | FGFR3 | C0026764 | Multiple Myeloma | 1 | CGI;CTD_human |
Tgene | FGFR3 | C0036631 | Seminoma | 1 | CTD_human |
Tgene | FGFR3 | C0039743 | Thanatophoric Dysplasia | 1 | CTD_human |
Tgene | FGFR3 | C0152423 | Congenital small ears | 1 | GENOMICS_ENGLAND |
Tgene | FGFR3 | C0206726 | gliosarcoma | 1 | ORPHANET |
Tgene | FGFR3 | C0221356 | Brachycephaly | 1 | ORPHANET |
Tgene | FGFR3 | C0265529 | Plagiocephaly | 1 | ORPHANET |
Tgene | FGFR3 | C0334082 | NEVUS, EPIDERMAL (disorder) | 1 | CTD_human;UNIPROT |
Tgene | FGFR3 | C0334588 | Giant Cell Glioblastoma | 1 | ORPHANET |
Tgene | FGFR3 | C0406803 | Syringocystadenoma Papilliferum | 1 | GENOMICS_ENGLAND |
Tgene | FGFR3 | C1336708 | Testicular Germ Cell Tumor | 1 | CTD_human;UNIPROT |
Tgene | FGFR3 | C1837218 | Cleft palate, isolated | 1 | CTD_human |
Tgene | FGFR3 | C4048328 | cervical cancer | 1 | CTD_human;UNIPROT |